Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Arndís F Ólafsdóttir"'
Autor:
Arndís F. Ólafsdóttir, Marcus Lind
Publikováno v:
Frontiers in Clinical Diabetes and Healthcare, Vol 4 (2023)
IntroductionAs many people with type 1 diabetes find it hard to reach the recommended glycemic goals, even with CGM, this study aims to determine if a closer, digitally supported collaboration on interpreting CGM data together with a diabetes nurse c
Externí odkaz:
https://doaj.org/article/bb5260716b0245cf8087e859385cb4d1
Publikováno v:
Frontiers in Nutrition, Vol 10 (2023)
IntroductionDiet is an important factor in managing glycemic control in type 1 diabetes (T1D). Reducing carbohydrate intake may be important for stabilizing blood glucose levels in certain groups of patients with T1D. There are few studies examining
Externí odkaz:
https://doaj.org/article/2493beceff1a48c2987043eeca403c81
Autor:
Sara Hallström, Arndís F. Ólafsdóttir, Magnus Löndahl, Marcus Lind, Aldina Pivodic, Hans Wedel, Ann-Marie Svensson
Publikováno v:
Diabetologia
Aims/hypothesis The aim of this work was to study the incidence over time of lower extremity amputations and determine variables associated with increased risk of amputations in people with type 1 diabetes. Methods Individuals with type 1 diabetes re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e70a79bc9abe9e08ee6dfeb0d4e832
https://doi.org/10.1007/s00125-021-05550-z
https://doi.org/10.1007/s00125-021-05550-z
Autor:
Jarl Hellman, Sofia Dahlqvist, Jan Bolinder, Tim Heise, Marcus Lind, Henrik Albrektsson, Magnus Wijkman, Aldina Pivodic, Irl B. Hirsch, Erik Schwarcz, William H. Polonsky, Arndís F. Ólafsdóttir
Publikováno v:
Diabetes Care. 44:141-149
OBJECTIVE Continuous glucose monitoring (CGM) reduces HbA1c and time spent in hypoglycemia in people with type 1 diabetes (T1D) treated with multiple daily insulin injections (MDI) when evaluated over shorter time periods. It is unclear to what exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4f40324d8c33df629637ed30f9983c6
https://doi.org/10.2337/dc20-1468
https://doi.org/10.2337/dc20-1468
Autor:
Arndís F. Ólafsdóttir, Aldina Pivodic, Hans Wedel, Sara Hallström, Ann-Marie Svensson, Marcus Lind, Magnus Löndahl
Publikováno v:
Diabetes. 70
Background: Lower extremity amputations in people with diabetes is a major source of disability and distress and it constitutes a significant financial burden for the healthcare system. Risk factors and current risks for amputation in persons with ty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7d2afa9bac89155f5f2124172f62c9f
https://doi.org/10.2337/db21-52-or
https://doi.org/10.2337/db21-52-or
Autor:
Jan Bolinder, Aldina Pivodic, Magnus Wijkman, Erik Schwarcz, Irl B. Hirsch, Tim Heise, Thomas Nyström, Jarl Hellman, William H. Polonsky, Elsa Ahlén, Magnus Ekelund, Arndís F. Ólafsdóttir, Marcus Lind
Publikováno v:
Diabetes, Obesity & Metabolism
Aim To identify responders to continuous glucose monitoring (CGM) in relation to reductions in HbA1c and percentage of time spent in hypoglycaemia after initiation of CGM for individuals with type 1 diabetes treated with multiple daily insulin inject
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b3f69ed7afb49bee1a941336c098743
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-172239
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-172239
Autor:
William Polonsky, Tim Heise, Henrik Albrektsson, Erik Schwarcz, Magnus Wijkman, Jarl Hellman, Aldina Pivodic, Sofia Dahlqvist, Jan Bolinder, Irl B. Hirsch, Arndís F. Ólafsdóttir, Marcus Lind
Objective: Continuous Glucose Monitoring (CGM) reduces HbA1c and time spent in hypoglycemia in persons with type 1 diabetes treated with multiple daily insulin injections (MDI) when evaluated over shorter time periods. It is unclear to what extent CG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35616713b262468d66dbbcbd227418c6
https://doi.org/10.2337/figshare.13042586.v1
https://doi.org/10.2337/figshare.13042586.v1
Autor:
William H. Polonsky, Magnus Wijkman, Magnus Ekelund, Jarl Hellman, Marcus Lind, Aldina Pivodic, Elsa Ahlén, Arndís F. Ólafsdóttir, Thomas Nyström, Jan Bolinder, Irl B. Hirsch, Tim Heise, Erik Schwarcz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ddd3a94a5b4561cdf286fa2cebed8a9f
https://doi.org/10.1111/dom.14257/v2/response1
https://doi.org/10.1111/dom.14257/v2/response1
Publikováno v:
J Diabetes Sci Technol
Background: Recent guidelines have been developed for continuous glucose monitoring (CGM) metrics in persons with diabetes. To understand what glucose profiles should be judged as normal in clinical practice and glucose-lowering trials, we examined t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ce2c86c76d937f58449fb7152e2685
https://europepmc.org/articles/PMC8861786/
https://europepmc.org/articles/PMC8861786/
Autor:
Shilan Seyed Ahmadi, Erik Schwarcz, William H. Polonsky, Klara Westman, Sofia Dahlqvist, Aldina Pivodic, Marcus Lind, Irl B. Hirsch, Tim Heise, Jarl Hellman, Magnus Wijkman, Arndís F. Ólafsdóttir, Magnus Ekelund
OBJECTIVE According to recent guidelines, individuals with type 1 diabetes should spend RESEARCH DESIGN AND METHODS In the GOLD randomized crossover trial, 161 individuals with type 1 diabetes treated with multiple daily insulin injections (MDI) were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c1b0f5e3bf783253e92be84536f6212
https://doi.org/10.2337/figshare.12357506.v2
https://doi.org/10.2337/figshare.12357506.v2